Free Trial

Alcon (ALC) Stock Forecast & Price Target

$96.65
-0.51 (-0.52%)
(As of 09/18/2024 ET)

Alcon - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 15 Wall Street analysts who have issued ratings for Alcon in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 1 has given a sell rating, 1 has given a hold rating, and 13 have given a buy rating for ALC.

Consensus Price Target

$99.74
3.20% Upside
High Forecast$110.00
Average Forecast$99.74
Low Forecast$85.00

According to the 15 analysts' twelve-month price targets for Alcon, the average price target is $99.74. The highest price target for ALC is $110.00, while the lowest price target for ALC is $85.00. The average price target represents a forecasted upside of 3.20% from the current price of $96.65.

TypeCurrent Forecast
9/19/23 to 9/18/24
1 Month Ago
8/20/23 to 8/19/24
3 Months Ago
6/21/23 to 6/20/24
1 Year Ago
9/19/22 to 9/19/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
13 Buy rating(s)
12 Buy rating(s)
12 Buy rating(s)
7 Buy rating(s)
Hold
1 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
3 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
2 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$99.74$97.28$94.71$88.81
Forecasted Upside3.20% Upside11.64% Upside12.42% Upside15.96% Upside

ALC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ALC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Alcon Stock vs. The Competition

TypeAlconMedical CompaniesS&P 500
Consensus Rating Score
2.80
2.77
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside3.20% Upside1,009.48% Upside7.94% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/12/2024BTIG Research
2 of 5 stars
 Boost TargetBuy ➝ Buy$98.00 ➝ $104.00+5.88%
9/10/2024Royal Bank of Canada
4 of 5 stars
J. Reynolds-Clar
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Perform ➝ Outperform
8/22/2024Wells Fargo & Company
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$94.00 ➝ $105.00+9.88%
8/22/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$103.00 ➝ $110.00+16.25%
8/22/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$104.00 ➝ $110.00+16.25%
8/21/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$101.00 ➝ $101.00+4.66%
Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad)

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…
7/15/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderweight ➝ Equal Weight$65.00 ➝ $85.00-7.35%
5/15/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$95.00 ➝ $100.00+12.02%
5/15/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$100.00 ➝ $105.00+17.62%
4/10/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$100.00+20.95%
3/4/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$90.00 ➝ $100.00+16.31%
2/29/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$87.00 ➝ $92.00+7.39%
2/29/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$93.00 ➝ $96.60+13.10%
12/18/2023Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Sell
11/20/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$94.00 ➝ $88.00+23.40%
8/17/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$79.80 ➝ $89.30+11.29%
3/1/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSell ➝ Hold
11/21/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetCHF 84 ➝ CHF 80
11/17/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$67.00 ➝ $69.00+4.03%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:51 PM ET.

ALC Forecast - Frequently Asked Questions

What is Alcon's forecast for 2024?

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Alcon is $99.74, with a high forecast of $110.00 and a low forecast of $85.00.

Should I buy or sell Alcon stock right now?

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last year. There is currently 1 sell rating, 1 hold rating and 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ALC shares.

Does Alcon's stock price have much upside?

According to analysts, Alcon's stock has a predicted upside of 11.69% based on their 12-month stock forecasts.

Has Alcon been upgraded by Wall Street analysts recently?

Over the previous 90 days, Alcon's stock had 2 upgrades by analysts.

What analysts cover Alcon?

Alcon has been rated by research analysts at BTIG Research, Morgan Stanley, Needham & Company LLC, Oppenheimer, Robert W. Baird, Royal Bank of Canada, and Wells Fargo & Company in the past 90 days.

Do Wall Street analysts like Alcon more than its competitors?

Analysts like Alcon more than other "medical" companies. The consensus rating score for Alcon is 2.80 while the average consensus rating score for "medical" companies is 2.77. Learn more on how ALC compares to other companies.



This page (NYSE:ALC) was last updated on 9/18/2024 by MarketBeat.com Staff
From Our Partners